Harley I. Kornblum

Harley I. Kornblum

Auto-generated profile, based on publicly available information

Harley I. Kornblum

Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, USA

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
HHHouman D. Hemmati
Houman D. Hemmati
INIchiro Nakano
Ichiro Nakano
JLJorge A. Lazareff
Jorge A. Lazareff
MMMichael Masterman-Smith
Michael Masterman-Smith
DGDaniel H. Geschwind
Daniel H. Geschwind
HKHarley I. Kornblum
Harley I. Kornblum
Pediatric brain tumors are significant causes of morbidity and mortality. It has been hypothesized that they derive from self-renewing multipotent neural stem cells. Here, we tested whether different pediatric brain tumors, including medulloblastomas and gliomas, contain cells with properties similar to neural stem cells. We find that tumor-derived progenitors form neurospheres that can be passaged at clonal density and are able to self-renew. Under conditions promoting differentiation, individual cells are multipotent, giving rise to both neurons and glia, in proportions that reflect the tumor of origin. Unlike normal neural stem cells, however, tumor-derived progenitors have an unusual capacity to proliferate and sometimes differentiate into abnormal cells with multiple differentiation markers. Gene expression analysis reveals that both whole tumors and tumor-derived neurospheres express many genes characteristic of neural and other stem cells, including CD133, Sox2 , musashi-1, bmi-1 , maternal embryonic leucine zipper kinase, and phosphoserine phosphatase, with variation from tumor to tumor. After grafting to neonatal rat brains, tumor-derived neurosphere cells migrate, produce neurons and glia, and continue to proliferate for more than 4 weeks. The results show that pediatric brain tumors contain neural stem-like cells with altered characteristics that may contribute to tumorigenesis. This finding may have important implications for treatment by means of specific targeting of stem-like cells within brain tumors.

23 February 2017 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
KLKirsten Ludwig
Kirsten Ludwig
HKHarley I. Kornblum
Harley I. Kornblum

23 February 2009 in Stem Cells
Verified
Journal Article
Closed access
PDF file
SKSaravanan Karumbayaram
Saravanan Karumbayaram
BNBennett G. Novitch
Bennett G. Novitch
MPMichaela Patterson
Michaela Patterson
JUJoy A. Umbach
Joy A. Umbach
LRLaura Richter
Laura Richter
WLWilliam E. Lowry
William E. Lowry

22 December 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MGMatthias Groszer
Matthias Groszer
RERebecca Erickson
Rebecca Erickson
DSDeirdre D. Scripture-Adams
Deirdre D. Scripture-Adams
JDJoseph D. Dougherty
Joseph D. Dougherty
JBJanel Le Belle
Janel Le Belle
HWHong Wu
Hong Wu
Previous studies have demonstrated that a small subpopulation of brain tumor cells share key characteristics with neural stem/progenitor cells in terms of phenotype and behavior. These findings suggest that brain tumors might contain “cancer stem cells” that are critical for tumor growth. However, the molecular pathways governing such stem cell-like behavior remain largely elusive. Our previous study suggests that the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) tumor suppressor gene, one of the most frequently mutated genes in glioblastomas, restricts neural stem/progenitor cell proliferationin vivo. In the present study, we sought to determine the role of PTEN in long-term maintenance of stem cell-like properties, cell cycle entry and progression, and growth factor dependence and gene expression. Our results demonstrate an enhanced self-renewal capacity and G0-G1cell cycle entry and decreased growth factor dependency ofPtennull neural/stem progenitor cells. Therefore, loss of PTEN leads to cell physiological changes, which collectively are sufficient to increase the pool of self-renewing neural stem cells and promote their escape from the homeostatic mechanisms of proliferation control.

22 January 2009 in Stem Cells
Verified
Journal Article
Open access
PDF file
DLDan R. Laks
Dan R. Laks
MMMichael Masterman-Smith
Michael Masterman-Smith
KVKoppany Visnyei
Koppany Visnyei
BABrigitte Angenieux
Brigitte Angenieux
NONicholas M. Orozco
Nicholas M. Orozco
HKHarley I. Kornblum
Harley I. Kornblum
Renewable neurosphere formation in culture is a defining characteristic of certain brain tumor initiating cells. This retrospective study was designed to assess the relationship among neurosphere formation in cultured human glioma, tumorigenic capacity, and patient clinical outcome. Tumor samples were cultured in neurosphere conditions from 32 patients with glioma, including a subpopulation of 15 patients with primary glioblastoma. A subsample of renewable neurosphere cultures was xenografted into mouse brain to determine if they were tumorigenic. Our study shows that both renewable neurosphere formation and tumorigenic capacity are significantly associated with clinical outcome measures. Renewable neurosphere formation in cultured human glioma significantly predicted an increased hazard of patient death and more rapid tumor progression. These results pertained to both the full population of glioma and the subpopulation of primary glioblastoma. Similarly, there was a significant hazard of progression for patients whose glioma had tumorigenic capacity. Multivariate analysis demonstrated that neurosphere formation remained a significant predictor of clinical outcome independent of Ki67 proliferation index. In addition, multivariate analysis of neurosphere formation, tumor grade and patient age, demonstrated that neurosphere formation was a robust, independent predictor of glioma tumor progression. Although the lengthy duration of this assay may preclude direct clinical application, these results exemplify how neurosphere culture serves as a clinically relevant model for the study of malignant glioma. Furthermore, this study suggests that the ability to propagate brain tumor stem cells in vitro is associated with clinical outcome. Disclosure of potential conflicts of interest is found at the end of this article.

1 August 2005 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
INIchiro Nakano
Ichiro Nakano
APAndres A. Paucar
Andres A. Paucar
RBRuchi Bajpai
Ruchi Bajpai
JDJoseph D. Dougherty
Joseph D. Dougherty
AZAmani Zewail
Amani Zewail
HKHarley I. Kornblum
Harley I. Kornblum
Maternal embryonic leucine zipper kinase (MELK) was previously identified in a screen for genes enriched in neural progenitors. Here, we demonstrate expression of MELK by progenitors in developing and adult brain and that MELK serves as a marker for self-renewing multipotent neural progenitors (MNPs) in cultures derived from the developing forebrain and in transgenic mice. Overexpression of MELK enhances (whereas knockdown diminishes) the ability to generate neurospheres from MNPs, indicating a function in self-renewal. MELK down-regulation disrupts the production of neurogenic MNP from glial fibrillary acidic protein (GFAP)–positive progenitors in vitro. MELK expression in MNP is cell cycle regulated and inhibition of MELK expression down-regulates the expression of B-myb, which is shown to also mediate MNP proliferation. These findings indicate that MELK is necessary for proliferation of embryonic and postnatal MNP and suggest that it regulates the transition from GFAP-expressing progenitors to rapid amplifying progenitors in the postnatal brain.